Wilson Sonsini - ECP

insight detail

Wilson Sonsini Advises Cambridge Epigenetix on IP Matters Related to $88 Million Series D

  • 11/02/21
  • Client Highlights
  • Life Sciences
  • Biotech

Copyright © 2021 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.

We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content. For more information or to opt-out, visit our privacy policy.